DNTH
Dianthus Therapeutics, Inc. /DE/Company with tickers: DNTH
CIK
1690585
CUSIP
252828108
Shares Outstanding
54,666,233
13F Activity (30d)
224 filings
223 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-21 | Lawton Alison Frances | Director | Award | 6,090 |
| 2026-05-21 | Romano Steven J. | EVP and Chief R&D Officer | Award | 6,090 |
| 2026-05-21 | Soteropoulos Paula | Director | Award | 6,090 |
| 2026-05-21 | Violin Jonathan | Director | Award | 6,090 |
| 2026-05-21 | Read Simon | Director | Award | 6,090 |
| 2026-05-21 | KANGO SUJAY | Director | Award | 6,090 |
| 2026-05-21 | McGeorge Anne | Director | Award | 6,090 |
| 2026-05-08 | Soteropoulos Paula | Director | Convert | 599 |
| 2026-05-08 | Soteropoulos Paula | Director | Convert | 599 |
| 2026-05-08 | Soteropoulos Paula | Director | Sell | 599 |
| 2026-04-09 | Savitz Ryan | EVP, CFO & CBO | Sell | 8,224 |
| 2026-04-09 | Savitz Ryan | EVP, CFO & CBO | Convert | 8,224 |
| 2026-04-09 | Savitz Ryan | EVP, CFO & CBO | Convert | 8,224 |
| 2026-03-31 | Soteropoulos Paula | Director | Sell | 599 |
| 2026-03-31 | Soteropoulos Paula | Director | Convert | 599 |
| 2026-03-31 | Soteropoulos Paula | Director | Convert | 599 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 800 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 21,825 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 59,800 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Convert | 40,000 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 1,485 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 19,469 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 1,390 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 7,232 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Convert | 40,000 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Convert | 74,367 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Sell | 2,366 |
| 2026-03-31 | Savitz Ryan | EVP, CFO & CBO | Convert | 74,367 |
| 2026-03-24 | Soteropoulos Paula | Director | Sell | 27,594 |
| 2026-03-24 | Soteropoulos Paula | Director | Convert | 27,594 |
| 2026-03-24 | Soteropoulos Paula | Director | Convert | 27,594 |
| 2026-03-16 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 59,700 |
| 2026-03-16 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 5,592 |
| 2026-03-16 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 5,592 |
| 2026-03-16 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 59,700 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Sell | 43,505 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Sell | 900 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Sell | 200 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 122,918 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Sell | 65,517 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Sell | 12,796 |
| 2026-03-12 | Garcia Marino | Director, CEO AND PRESIDENT | Convert | 122,918 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 12,500 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 12,500 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 8,332 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 7,998 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 5,000 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 5,000 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Sell | 33,830 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 7,998 |
| 2026-03-12 | Randhawa Simrat | EVP, Head of R&D | Convert | 8,332 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 17,500 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 16,182 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 10,000 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Sell | 300 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Sell | 15,852 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 17,500 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Sell | 200 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Sell | 23,465 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 16,182 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Convert | 10,000 |
| 2026-03-12 | CARR EDWARD | Chief Financial Officer | Sell | 3,865 |
| 2026-02-03 | CARR EDWARD | Chief Financial Officer | Award | 55,000 |
| 2026-02-03 | Savitz Ryan | EVP, CFO & CBO | Award | 150,000 |
| 2026-02-03 | Veness Adam M | SVP, General Counsel and Sec. | Award | 100,000 |
| 2026-02-03 | Randhawa Simrat | EVP, Head of R&D | Award | 150,000 |
| 2026-02-03 | Garcia Marino | Director, CEO AND PRESIDENT | Award | 355,000 |
| 2025-12-04 | Savitz Ryan | EVP, CFO & CBO | Convert | 20,000 |
| 2025-12-04 | Savitz Ryan | EVP, CFO & CBO | Convert | 20,000 |
| 2025-12-04 | Savitz Ryan | EVP, CFO & CBO | Sell | 20,000 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 31,250 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Sell | 109,031 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 37,494 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 31,250 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 40,287 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 40,287 |
| 2025-11-14 | Randhawa Simrat | EVP, Head of R&D | Convert | 37,494 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Sell | 26,166 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Convert | 83,978 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Sell | 42,765 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Convert | 83,978 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Convert | 3,529 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Sell | 18,576 |
| 2025-11-13 | Randhawa Simrat | EVP, Head of R&D | Convert | 3,529 |
| 2025-09-30 | Garcia Marino | Director, CEO AND PRESIDENT | Award | 120,000 |
| 2025-09-23 | Savitz Ryan | EVP, CFO & CBO | Award | 60,000 |
| 2025-09-23 | Randhawa Simrat | EVP, Head of R&D | Award | 60,000 |
| 2025-09-09 | Savitz Ryan | EVP, CFO & CBO | Sell | 20,000 |
| 2025-09-09 | Savitz Ryan | EVP, CFO & CBO | Convert | 20,000 |
| 2025-09-09 | Savitz Ryan | EVP, CFO & CBO | Convert | 20,000 |
| 2025-05-22 | Read Simon | Director | Other | 0 |
| 2025-05-22 | Violin Jonathan | Director | Award | 12,500 |
| 2025-05-22 | Lawton Alison Frances | Director | Award | 12,500 |
| 2025-05-22 | Read Simon | Director | Award | 25,000 |
| 2025-05-22 | Soteropoulos Paula | Director | Award | 12,500 |
| 2025-05-22 | Romano Steven J. | EVP and Chief R&D Officer | Award | 12,500 |
| 2025-05-22 | McGeorge Anne | Director | Award | 12,500 |
| 2025-03-04 | KANGO SUJAY | Director | Other | 0 |
| 2025-03-04 | KANGO SUJAY | Director | Award | 25,000 |
| 2025-02-03 | Savitz Ryan | EVP, CFO & CBO | Award | 150,000 |